Terho Heikkinen
Professor of Paediatrics, MD, PhD
teheikki@utu.fi ORCID identifier: https://orcid.org/0000-0001-6504-0116 |
Paediatric infectious diseases; respiratory infections; respiratory viruses; vaccinations; influenza; respiratory syncytial virus; otitis media
Respiratory infections in children; RESCEU (EU/IMI-funded project 2017-2021); INFORM study
Professor Terho Heikkinen graduated from the Medical School at the
University of Turku in 1984, where he also specialized in Paediatrics and Paediatric
Infectious Diseases. He defended his thesis on Development and prevention of acute
otitis media in children in 1994. Having received the European Society for
Paediatric Infectious Diseases Fellowship Award, he worked in 1996-1998 as
a post-doc Research Fellow at the University of Texas Medical Branch at
Galveston, USA. Subsequently, he worked as a Senior Clinical Researcher and
Clinical Lecturer at the Department of Paediatrics, University of Turku. Since
2016, he has been Professor of Paediatrics at
the Faculty of Medicine, University of Turku.
During the years, Terho Heikkinen has served as the chairman or a board member
of several international and domestic societies in the field of paediatric
infectious diseases, including the President of the World Society for
Pediatric Infectious Diseases. He is currently a board member of the European Scientific
Working Group on Influenza (ESWI), a scientific advisory board and executive committee member of the global Respiratory Syncytial Virus Network (ReSViNET), and the chairman of the Nordic Research Network for Paediatric Infectious Diseases (NORDPID).
Terho Heikkinen´s major research interest lies in respiratory infections,
especially those caused by influenza or respiratory syncytial viruses. In year 2000, he founded his own research group and initiated a long-term research project on respiratory virus infections in children,
including the etiology, epidemiology, diagnosis, treatment, prevention, and
overall societal impact of these infections and their complications.
Terho Heikkinen has been
actively involved in international research collaboration. In 2014, he was a founding member of ReSViNET, a global respiratory syncytial virus research network.
He is also a principal investigator in RESCEU (Respiratory syncytial virus
consortium in Europe) that in 2017 received 5-year EU/IMI funding for research
on the burden of respiratory syncytial virus infections in Europe. He was also a founding member of the Nordic Research Network for Paediatric Infectious Diseases (NORDPID) that was established in 2018.
Since 1999, Terho Heikkinen has worked as a full-time
teacher of paediatrics at the Department of Paediatrics, University of Turku. He
is also responsible for the organization of the biannual International Course
of Paediatrics & Adolescent Medicine for international Erasmus students. He
has given 188 invited lectures at various international and domestic academic
meetings.
- The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virusRespiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape (2024)
- Nature CommunicationsLancet Infectious Diseases
(A1 Refereed original research article in a scientific journal) - The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in childrenThe burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study (2024)
- Cell Reports Medicine
(A1 Refereed original research article in a scientific journal) - Uudet keinot käyttöön RSV:n ehkäisyssä (2024)
- Duodecim
(D1 Article in a professional journal) - Burden of Respiratory Syncytial Virus in the European Union: estimation of RSV-associated hospitalizations in children under 5 years (2023)
- Journal of Infectious Diseases
(A1 Refereed original research article in a scientific journal) - Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries (2023)
- VaccineThe Lancet Respiratory Medicine
(A1 Refereed original research article in a scientific journal) - Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe (2023)
- Vaccine
(A1 Refereed original research article in a scientific journal) - Hengitystieinfektiot: influenssa (2023) Lastentaudit Peltola Ville, Heikkinen Terho
(D2 Article in a professional compilation book) - Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data (2023)
- Lancet Infectious Diseases
(A1 Refereed original research article in a scientific journal) - (2023)
(A2 Refereed review article in a scientific journal ) - (2023)
(A1 Refereed original research article in a scientific journal)



